Neutrophil-to-lymphocyte Ratio (NLR) as an Index of Response to Treatment in Patients with Hepatocellular Carcinoma after Receiving Trans-arterial Chemoembolization (TACE)
Neda Shayegan, Niloofar Ayoobi, Esmaeil Mohammadi, Hajir Saberi, Faeze Salahshour, Forough Alborzi, Nahid Sadighi, Mohammad Taher
doi: https://doi.org/10.1101/2023.05.16.23290061
Neda Shayegan
1Division of Gastroenterology & Hepatology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
Niloofar Ayoobi
2Department of Radiology, Imam Khomeini Hospital, Tehran University of Medical Science, Tehran, Iran
Esmaeil Mohammadi
2Department of Radiology, Imam Khomeini Hospital, Tehran University of Medical Science, Tehran, Iran
Hajir Saberi
3Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
Faeze Salahshour
2Department of Radiology, Imam Khomeini Hospital, Tehran University of Medical Science, Tehran, Iran
3Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
4Liver Transplantation Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
Forough Alborzi
1Division of Gastroenterology & Hepatology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
Nahid Sadighi
2Department of Radiology, Imam Khomeini Hospital, Tehran University of Medical Science, Tehran, Iran
Mohammad Taher

Data Availability
All the material and data used in this manuscript can be provided through official request to the corresponding author.
Posted May 17, 2023.
Neutrophil-to-lymphocyte Ratio (NLR) as an Index of Response to Treatment in Patients with Hepatocellular Carcinoma after Receiving Trans-arterial Chemoembolization (TACE)
Neda Shayegan, Niloofar Ayoobi, Esmaeil Mohammadi, Hajir Saberi, Faeze Salahshour, Forough Alborzi, Nahid Sadighi, Mohammad Taher
medRxiv 2023.05.16.23290061; doi: https://doi.org/10.1101/2023.05.16.23290061
Neutrophil-to-lymphocyte Ratio (NLR) as an Index of Response to Treatment in Patients with Hepatocellular Carcinoma after Receiving Trans-arterial Chemoembolization (TACE)
Neda Shayegan, Niloofar Ayoobi, Esmaeil Mohammadi, Hajir Saberi, Faeze Salahshour, Forough Alborzi, Nahid Sadighi, Mohammad Taher
medRxiv 2023.05.16.23290061; doi: https://doi.org/10.1101/2023.05.16.23290061
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)